These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
250 related items for PubMed ID: 31869431
1. Chronic activation of anti-oxidant pathways and iron accumulation in epileptogenic malformations. Zimmer TS, Ciriminna G, Arena A, Anink JJ, Korotkov A, Jansen FE, van Hecke W, Spliet WG, van Rijen PC, Baayen JC, Idema S, Rensing NR, Wong M, Mills JD, van Vliet EA, Aronica E. Neuropathol Appl Neurobiol; 2020 Oct; 46(6):546-563. PubMed ID: 31869431 [Abstract] [Full Text] [Related]
2. Downregulation of CD47 and CD200 in patients with focal cortical dysplasia type IIb and tuberous sclerosis complex. Sun FJ, Zhang CQ, Chen X, Wei YJ, Li S, Liu SY, Zang ZL, He JJ, Guo W, Yang H. J Neuroinflammation; 2016 Apr 19; 13(1):85. PubMed ID: 27095555 [Abstract] [Full Text] [Related]
3. Upregulation of the pathogenic transcription factor SPI1/PU.1 in tuberous sclerosis complex and focal cortical dysplasia by oxidative stress. Zimmer TS, Korotkov A, Zwakenberg S, Jansen FE, Zwartkruis FJT, Rensing NR, Wong M, Mühlebner A, van Vliet EA, Aronica E, Mills JD. Brain Pathol; 2021 Sep 19; 31(5):e12949. PubMed ID: 33786950 [Abstract] [Full Text] [Related]
4. Oxidative stress and inflammation in a spectrum of epileptogenic cortical malformations: molecular insights into their interdependence. Arena A, Zimmer TS, van Scheppingen J, Korotkov A, Anink JJ, Mühlebner A, Jansen FE, van Hecke W, Spliet WG, van Rijen PC, Vezzani A, Baayen JC, Idema S, Iyer AM, Perluigi M, Mills JD, van Vliet EA, Aronica E. Brain Pathol; 2019 May 19; 29(3):351-365. PubMed ID: 30303592 [Abstract] [Full Text] [Related]
5. mTOR Hyperactivity Levels Influence the Severity of Epilepsy and Associated Neuropathology in an Experimental Model of Tuberous Sclerosis Complex and Focal Cortical Dysplasia. Nguyen LH, Mahadeo T, Bordey A. J Neurosci; 2019 Apr 03; 39(14):2762-2773. PubMed ID: 30700531 [Abstract] [Full Text] [Related]
6. [Expression of autophagy-related proteins in malformations of cortical development]. Chen S, Piao Y, Fu Y, Li Z, Liu C, Lu D. Zhonghua Bing Li Xue Za Zhi; 2015 May 03; 44(5):305-9. PubMed ID: 26178210 [Abstract] [Full Text] [Related]
7. Activation of leukocyte immunoglobulin-like receptor B2 signaling pathway in cortical lesions of pediatric patients with focal cortical dysplasia type IIb and tuberous sclerosis complex. Yue J, Zhang C, Shi X, Wei Y, Liu L, Liu S, Yang H. Brain Dev; 2019 Nov 03; 41(10):829-838. PubMed ID: 31495513 [Abstract] [Full Text] [Related]
8. Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia. Talos DM, Sun H, Kosaras B, Joseph A, Folkerth RD, Poduri A, Madsen JR, Black PM, Jensen FE. Ann Neurol; 2012 Apr 03; 71(4):539-51. PubMed ID: 22447678 [Abstract] [Full Text] [Related]
9. Immunohistochemical characterization of the out-of frame splice variants GFAP Delta164/Deltaexon 6 in focal lesions associated with chronic epilepsy. Boer K, Middeldorp J, Spliet WG, Razavi F, van Rijen PC, Baayen JC, Hol EM, Aronica E. Epilepsy Res; 2010 Jun 03; 90(1-2):99-109. PubMed ID: 20430588 [Abstract] [Full Text] [Related]
10. Altered expression of the Plexin-B2 system in tuberous sclerosis complex and focal cortical dysplasia IIb lesions. Dai L, Huang J, Shen KF, Yang XL, Zhu G, Zhang L, Wang ZK, Liu SY, Liao X, Xu SL, Yang H, Li XY, Zhang CQ. Histol Histopathol; 2024 Sep 03; 39(9):1179-1195. PubMed ID: 38293776 [Abstract] [Full Text] [Related]
11. mTOR pathway activation in focal cortical dysplasia. Kumari K, Sharma MC, Kakkar A, Malgulwar PB, Pathak P, Suri V, Sarkar C, Chandra SP, Faruq M. Ann Diagn Pathol; 2020 Jun 03; 46():151523. PubMed ID: 32325422 [Abstract] [Full Text] [Related]
12. Downregulated GPR30 expression in the epileptogenic foci of female patients with focal cortical dysplasia type IIb and tuberous sclerosis complex is correlated with 18 F-FDG PET-CT values. Wang Z, Huang K, Yang X, Shen K, Yang L, Ruan R, Shi X, Wang M, Zhu G, Yang M, Zhang C, Lv S, Yang H, Fan X, Liu S. Brain Pathol; 2021 Mar 03; 31(2):346-364. PubMed ID: 33314369 [Abstract] [Full Text] [Related]
13. Expression of tuberin and hamartin in tuberous sclerosis complex-associated and sporadic cortical dysplasia of Taylor's balloon cell type. Grajkowska W, Kotulska K, Matyja E, Larysz-Brysz M, Mandera M, Roszkowski M, Domańska-Pakieła D, Lewik-Kowalik J, Jóźwiak S. Folia Neuropathol; 2008 Mar 03; 46(1):43-8. PubMed ID: 18368626 [Abstract] [Full Text] [Related]
14. Expression patterns of glial fibrillary acidic protein (GFAP)-delta in epilepsy-associated lesional pathologies. Martinian L, Boer K, Middeldorp J, Hol EM, Sisodiya SM, Squier W, Aronica E, Thom M. Neuropathol Appl Neurobiol; 2009 Aug 03; 35(4):394-405. PubMed ID: 19508443 [Abstract] [Full Text] [Related]
15. Doublecortin-like (DCL) expression in focal cortical dysplasia and cortical tubers. Boer K, Lucassen PJ, Spliet WG, Vreugdenhil E, van Rijen PC, Troost D, Jansen FE, Aronica E. Epilepsia; 2009 Dec 03; 50(12):2629-37. PubMed ID: 19583781 [Abstract] [Full Text] [Related]
16. mTOR-dependent abnormalities in autophagy characterize human malformations of cortical development: evidence from focal cortical dysplasia and tuberous sclerosis. Yasin SA, Ali AM, Tata M, Picker SR, Anderson GW, Latimer-Bowman E, Nicholson SL, Harkness W, Cross JH, Paine SM, Jacques TS. Acta Neuropathol; 2013 Aug 03; 126(2):207-18. PubMed ID: 23728790 [Abstract] [Full Text] [Related]
18. Downregulated formyl peptide receptor 2 expression in the epileptogenic foci of patients with focal cortical dysplasia type IIb and tuberous sclerosis complex. Huang K, Wang Z, He Z, Li Y, Li S, Shen K, Zhu G, Liu Z, Lv S, Zhang C, Yang H, Yang X, Liu S. Immun Inflamm Dis; 2022 Nov 03; 10(11):e706. PubMed ID: 36301030 [Abstract] [Full Text] [Related]